Similares

1. Is There a Need to Revise Goals in the Management of Dyslipidemias?
2. [The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications].
3. Combination lipid therapy: could teamwork make the dream work?
4. Atherosclerosis and inflammation: overview and updates.
5. The Role of Statins in Current Guidelines.
6. LDL-cholesterol reduction in chronic kidney disease: options beyond statins.
7. Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk?
8. The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.
9. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
10. Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease.